Focus
AYLA bioscience's goal is to eradicate cancer by developing personalized
immunotherapies to fight multiple cancer types. Our approach focuses on the individual
nature of a patient’s tumor and seeks.
These antigens, called tumor-specific neoantigens, offer attractive therapeutic targets
because they are non-self and tumor-specific, and are key targets.